Acute myeloid leukemia: open trials in Greece

8 open trials have a site in Greece. Registry data; only the trial team decides who can take part.

NCT06788509
A Rollover Study for Continued Study Treatment and Ongoing Safety Monitoring
Trial Treatment · Phase 1 · Janssen Research & Development, LLC
General Hospital of Athens - Alexandra, Athens
Registry updated 2026-11-04
NCT06852222
A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)
Trial Treatment · Phase 3 · Janssen Research & Development, LLC
University Hospital of Alexandroupolis, Alexandroupoli · Evaggelismos Hospital, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Ioannina, Ioannina · General University Hospital of Patras, Rio · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki · AHEPA University General Hospital of Thessaloniki, Thessaloniki
Registry updated 2026-11-03
NCT07211958
Study of Revumenib in Combination With Intensive Chemotherapy in Newly Diagnosed Acute Myeloid Leukemia (AML) With a NPM1 Mutation
Trial Treatment · Phase 3 · Syndax Pharmaceuticals
University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · General University Hospital of Larissa, Larissa · General University Hospital Of Patras, Patras
Registry updated 2026-10-21
NCT05735704
Early Detection and Screening of Hematological Malignancies - SANGUINE
Research · JaxBio Ltd
National and Kapodistrian University of Athens (NKUA), Athens
Registry updated 2026-10-15
NCT07007312
Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML
Trial Treatment · Phase 3 · Kura Oncology, Inc.
University General Hospital of Alexandroupoli, Alexandroupoli · Laiko General Hospital of Athens, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · University General Hospital of Ioannina, Ioannina · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-10-13
2025-521875-30-00
Administration of Gilteritinib to eliminate MRD in patients with AML and FLT3-ITD mutation.
Trial Treatment · Phase 2 · Hellenic Society Of Hematology
Evaggelismos Hospital, Athens · Laiko General Hospital of Athens, Athens · University General Hospital "ATTIKON" - General Hospital of West Attica "H AGIA VARVARA", Chaïdári · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-10-12
NCT05907057
An Open-label Phase 3b Study of Ivosidenib in Combination With Azacitidine in Adult Patients Newly Diagnosed With IDH1m Acute Myeloid Leukemia (AML) Ineligible for Intensive Induction Chemotherapy.
Trial Treatment · Phase 3 · Servier Affaires Médicales
Evangelismos S A, Athens · University General Hospital Attikon, Athens · Laiko General Hospital of Athens, Athens · University General Hospital of Heraklion, Heraklion · General University Hospital Of Patras, Patras · Geniko Nosokomeio Thessalonikis George Papanikolaou, Thessaloniki
Registry updated 2026-05-08
NCT05211570
AB8939 in Patients With Relapsed/Refractory Acute Myeloid Leukemia
Trial Treatment · Phase 1/2 · AB Science
“Attikon” University General Hospital of Athens, athens · Laiko General Hospital of Athens, Athens · Evaggelismos General Hospital of Athens, Athens · Universtiy General Hospital of Patra, Patra
Registry updated 2025-10-02

All Acute myeloid leukemia trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error